NSC |
Compound |
Enrichment |
Correlation |
NSC 683564 |
2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- |
0.0361455178924431 |
0.37294124 |
NSC 685865 |
Null |
0.0361455178924431 |
-0.048587165 |
NSC 686556 |
Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- |
0.0361455178924431 |
0.020421863 |
NSC 688526 |
Null |
0.0361455178924431 |
-0.072848377 |
NSC 694234 |
Null |
0.0361455178924431 |
-0.067326149 |
NSC 699092 |
Null |
0.0361455178924431 |
0.21115811 |
NSC 702045 |
2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- |
0.0361455178924431 |
0.30743856 |
NSC 723906 |
1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline |
0.0361455178924431 |
0.34156534 |
NSC 724784 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 |
0.0361455178924431 |
0.30812152 |
NSC 750493 |
2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one |
0.0393863597626316 |
0.40791543 |